AMSS values (baseline, 30-week, and change) stratified (< 8 and ≥ 8) by HADS-D and HADS-A values

Patient groupsBaseline AMSS: median (IQR)30-week AMSS: median (IQR)∆AMSS: median (IQR)
HADS-D ≥ 8
P, n = 4445 (39, 54)44.5 (36.5, 50)–3 (–9, 3)
TU, n = 3550 (42, 55)42 (31, 51)–6 (–11, 1)
HADS-D < 8
P, n = 5034 (27, 38)31 (26, 41)–2 (–5, 3)
TU, n = 4135 (31, 40)31(28, 35)–5 (–7, –1)
HADS-A ≥ 8
P, n = 3445 (38, 57)44 (31, 53)–2.5 (–10, 2)
TU, n = 3747 (40, 54)41 (31, 51)–3 (–10, 2)
HADS-A < 8
P, n = 6036 (29.5, 41)34.5 (26.5, 42)–2 (–6, 3)
TU, n = 3935 (32, 41)31 (27, 38)–6 (–9, –2)

∆AMSS: changes in ageing male symptom scale; HADS-A: Hospital Anxiety and Depression Scale-anxiety; HADS-D: Hospital Anxiety and Depression Scale-depression; IQR: interquartile range; P: placebo; TU: testosterone undecanoate